InsidersTradesSigma
Follow the LABCORP HOLDINGS INC share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €27bn. The latest transaction was disclosed on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: KERRII B ANDERSON. All data is openly available.
Analysts rate LABCORP HOLDINGS INC Buy (bullish), based on 16 analysts. Average price target: US$341.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
LABCORP HOLDINGS INC is a company specializing in diagnostic and research services. It provides laboratory tests and health solutions to clients worldwide.